首页> 美国卫生研究院文献>other >How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa

【2h】

How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa

机译：您能走多低：撒哈拉以南非洲血液恶性肿瘤患者的血小板输注安全阈值是多少

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDespite the importance of platelet transfusions in treatment of hematologic cancer patients, the optimal platelet count threshold for prophylactic transfusion is unknown in sub-Saharan Africa.

机译：背景尽管血小板输注在血液系统癌症患者的治疗中非常重要，但在撒哈拉以南非洲，预防性输血的最佳血小板计数阈值尚不清楚。

著录项

期刊名称 other
作者
Henry Ddungu; Elizabeth M. Krantz; Isaac Kajja; Sandra Naluzze; Hanifah Nabbanja; Flavia Nalubwama; Warren Phipps; Jackson Orem; Noah Kiwanuka; Anna Wald;
展开▼
作者单位

展开▼
年(卷),期 -1(14),2
年度 -1
页码 e0211648
总页数 12
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer Institute [J] . Henry Ddungu, Elizabeth M. Krantz, Isaac Kajja, Scientific reports. . 2020,第1期

机译：撒哈拉非洲血液恶性肿瘤患者的输血挑战：乌干达癌症研究所的前瞻性观察研究
2. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions. [J] . Stanworth SJ, Dyer C, Choo L, Transfusion medicine reviews . 2010,第3期

机译：所有血液系统恶性肿瘤和严重血小板减少症的患者都需要预防性血小板输注吗？评估预防性血小板输注有效性的临床试验（血小板预防试验）的背景，原理和设计。
3. Lower Risk of Platelet Antibody Production in Hematologic Patients after Platelet Transfusions Than Non-Hematologic Patients [J] . Lin Jeong-Shi, Lee Li-Hsuan, Liu Hsueng-Mei, Transfusion: The Journal of the American Association of Blood Banks . 2018,第S2期

机译：血液病变患者血液抗体产量的风险低于非血液学患者
4. Designing a conversational agent for patients with hematologic malignancies: Usability and Usefulness Study [C] . Maria Chatzimina, Helen Papadaki, Charalampos Pontikoglou, IEEE EMBS International Conference on Biomedical and Health Informatics . 2021

机译：设计血液学恶性肿瘤患者的会话剂：可用性和有用性研究
5. Platelet Transfusions in Hematological Disorders [D] . Karlstr?m, Cecilia. 2021

机译：血液疾病中的血小板输血
6. Note: Pharmacokinetics and Safety of a 7-Day Administration of Intravenous Itraconazole followed by a 14-Day Administration of Itraconazole Oral Solution in Patients with Hematologic Malignancy [O] . Marc A. Boogaerts, Johan Maertens, Ronald Van Der Geest, 2001

机译：注意：静脉伊曲康唑7天给药随后伊曲康唑口服液14天给药对血液系统恶性肿瘤的药代动力学和安全性
7. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa [O] . Henry Ddungu, Elizabeth M. Krantz, Isaac Kajja, 2019

机译：你能走多少钱：撒哈拉以南非血液学恶性肿瘤患者血小板输血的安全阈值是多少
8. Comparison of Platelet Transfusion as Fresh Whole Blood Versus Apheresis Platelets for Massively Transfused Combat Trauma patients. [R] . Perkins, J. G., Cap, A. P., Spinella, P. C., 2011

机译：大剂量输血作为新鲜全血与单纯血小板输注用于大规模输血创伤患者的比较。

How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa

摘要

著录项

相似文献

相关主题

期刊订阅